Fox Business - The Power to Prosper
Search Site

Bayer AG

Related Topics

  1. Marijn Dekkers
  2. Huntsman
  3. Linde AG
  4. Johnson & Johnson
  5. Kenneth Griffin
  6. Chrysler
Get updates on Bayer AG
Dow Chemical to Appeal $1.2 Billion Judgment in Price Fixing Case

Dow Chemical Co. (DOW) said it plans to appeal a federal court's judgment ordering the chemical company to pay $1.2 billion for the alleged price fixing of urethane chemicals.The fine was ordered by a U.S. District Court in Kansas City, Kansas, on Wednesday. Dow was one of several companies named in the price fixing suit, though other defendants had earlier settled the accusations while denying the charges. BASF Corp. had agreed to pay $51 million, while Bayer AG (BAYRY, BAYN.XE) agreed to pay $55 million and Huntsman International LLC agreed to pay $33 million."We believe that the jury's findings required that judgment should have been entered in Dow's favor and that the class should have been decertified based upon the Supreme Court's recent decision in the Comcast case, which involved the same plaintiffs' expert," the company said in a statement.The company noted it has always denied the plaintiffs' allegations of price fixing and said the matter was investigated by the U.S. Departm...

Read More ›

  1. Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash

    Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion (852 million euros) as the health-care firm aims to broaden its women's cont...

  2. Bayer To Buy Conceptus For $1.1 Billion

    Bayer AG on Monday said it will buy Conceptus, Inc. , whose flagship product is a surgery-free permanent birth control method, for $1.1 billion. Bayer intends to ext...

  3. Bayer to buy birth-control devices maker for $1.1 billion

    Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's heal...

  4. Mixed Results for Drug Companies

    AstraZeneca PLC (AZN.LN) said Thursday profit and sales fell for a fifth-consecutive quarter as the drug giant continues to suffer patent expiries that leave some of...

  5. Bayer Earnings Rise; Confirms Outlook

    Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience...

  6. Bayer Earnings, Sales Rise on HealthCare, CropScience; Confirms Outlook

    Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience...

  7. EARNINGS FORECAST TABLE: Bayer 1Q 2013

    The following is a summary of analysts' forecasts for Bayer AG (BAYN.XE) first-quarter results, based on a poll of 13 analysts conducted by Dow Jones Newswires (figu...

  8. UK's NICE Recommends Xarelto for Pulmonary Embolism

    The UK's healthcare cost-effectiveness body known as National Institute for Health and Care Excellence, or NICE, Friday recommended German pharmaceutical company Bay...

  9. Syngenta CEO: EU Insecticide Ban to Protect Bees Won't Hit Company This Year

    Syngenta AG's (SYNN.VX) chief executive Mike Mack said Thursday a proposed two-year ban by the European Commission on some insecticides that could be harmful to bees...

  10. Bayer and Monsanto Enter Into Licensing Agreements

    Germany's Bayer AG (BAYN.XE) said Tuesday its CropScience unit and Monsanto Co. (MON) have entered into a series of licensing agreements for next-generation and enab...

  11. J&J 1st-Quarter Profit Off 11% on Litigation Expenses, Acquisition-Related Items

    Johnson & Johnson's (JNJ) first-quarter earnings fell 11% on litigation expenses, impacts related to its Synthes Inc. acquisition and other items, though the acquisi...

  12. EUROPE MARKETS: Portugal Stocks Slump In Otherwise Upbeat Europe

    Portuguese stocks slumped in an otherwise upbeat Europe on Monday, after the country's high court struck down some of the austerity measures enacted as part of its 7...

  1. Bayer Buys Privately Held Pharmaceutical Firm in Darmstadt

    German pharmaceutical company Bayer AG (BAYN.XE) Thursday said it has bought privately held pharmaceutical firm Steigerwald Arzneimittelwerk GmbH in Darmstadt.MAIN F...

  2. Judge orders Dow Chemical to pay $1.2 billion in price-fixing case

    A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam product...

  3. Exclusive: Roche exploring sale of diabetes device unit

    Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the in...

  4. FDA Approves New Bayer Drug for Advanced Prostate Cancer

    Federal regulators approved a new drug Wednesday from Bayer AG (BAYN.XE, BAYRY) to treat certain types of advanced prostate cancer.The drug will be sold with the bra...

  5. Italy's ENI Loses Appeal to Cut 2006 Cartel Fine, Must Pay EUR181.5 Million

    Italian oil and gas giant ENI S.p.A. (E) has lost an appeal to get an earlier European Union cartel fine scrapped or reduced, after the bloc's top court upheld an ea...

  6. Bayer Discontinues BAY86-6150 Trials Due to Safety Issues

    German pharmaceutical company Bayer AG (BAYN.XE) said Friday it has discontinued a Phase II/III trial for its BAY 86-6150 compound in people with hemophilia A and he...

  7. Market Wrap for Monday, April 29: Stocks Start Week With a Rally

    The S&P 500 traded into record high territory on Monday as the markets started the week off on a strong note.A rally in U.S. stocks was sparked in part by better tha...

‹ Prev12345…Next ›
Freebase CC-BY
Source: Bayer AG on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL